These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 28522212)

  • 1. Bioengineering bacterial outer membrane vesicles as vaccine platform.
    Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
    Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in outer membrane vesicles of gram-negative bacteria as sub-unit vaccines - A review].
    Yi J; Liu Q; Kong Q
    Wei Sheng Wu Xue Bao; 2016 Jun; 56(6):911-21. PubMed ID: 29727152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
    Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
    Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
    Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
    Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gram-negative outer membrane vesicles in vaccine development.
    Collins BS
    Discov Med; 2011 Jul; 12(62):7-15. PubMed ID: 21794204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
    Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
    Lei EK; Azmat A; Henry KA; Hussack G
    Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
    Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
    Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-Demand Vaccine Production via Dock-and-Display of Biotinylated Antigens on Bacterial Extracellular Vesicles.
    Weyant KB; Oloyede A; DeLisa MP
    Methods Mol Biol; 2024; 2843():195-216. PubMed ID: 39141302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OMV Vaccines and the Role of TLR Agonists in Immune Response.
    Mancini F; Rossi O; Necchi F; Micoli F
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach.
    Daleke-Schermerhorn MH; Felix T; Soprova Z; Ten Hagen-Jongman CM; Vikström D; Majlessi L; Beskers J; Follmann F; de Punder K; van der Wel NN; Baumgarten T; Pham TV; Piersma SR; Jiménez CR; van Ulsen P; de Gier JW; Leclerc C; Jong WS; Luirink J
    Appl Environ Microbiol; 2014 Sep; 80(18):5854-65. PubMed ID: 25038093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with outer membrane vesicles and the fimbrial protein FlfA offers improved protection against lesions following challenge with Gallibacterium anatis.
    Persson G; Pors SE; Thøfner ICN; Bojesen AM
    Vet Microbiol; 2018 Apr; 217():104-111. PubMed ID: 29615242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles.
    Roier S; Blume T; Klug L; Wagner GE; Elhenawy W; Zangger K; Prassl R; Reidl J; Daum G; Feldman MF; Schild S
    Int J Med Microbiol; 2015 May; 305(3):298-309. PubMed ID: 25592265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane vesicles as platform vaccine technology.
    van der Pol L; Stork M; van der Ley P
    Biotechnol J; 2015 Sep; 10(11):1689-706. PubMed ID: 26912077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling of Gram-negative bacterial outer membrane vesicles: Current perspectives.
    Lee J; Kim OY; Gho YS
    Proteomics Clin Appl; 2016 Oct; 10(9-10):897-909. PubMed ID: 27480505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The
    König E; Gagliardi A; Riedmiller I; Andretta C; Tomasi M; Irene C; Frattini L; Zanella I; Berti F; Grandi A; Caproni E; Fantappiè L; Grandi G
    Front Immunol; 2021; 12():752168. PubMed ID: 34819933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.
    van den Berg van Saparoea HB; Houben D; de Jonge MI; Jong WSP; Luirink J
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29439988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.